Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using awake prone positioning for patients with acute hypoxic respiratory failure due to pneumonia

Official title: Awake PROne Positioning in PatientS With Acute Hypoxemic Respiratory Failure in Germany - A Randomized Controlled Study

Run by Universitätsklinikum Hamburg-Eppendorf · NCT06931938 · Data updated 2026-11-12

This study is testing if having patients with pneumonia-related breathing problems lie on their stomachs while awake can help them breathe better and reduce the need for breathing tubes.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment342 (estimated)
SponsorUniversitätsklinikum Hamburg-Eppendorf
Academic / other
Locations1 site (Hamburg, Free and Hanseatic City of Hamburg)
StatusRecruiting
StartedApril 11, 2025
Main results expectedDecember 30, 2026
Study endsJune 30, 2027
Registry record updatedMay 4, 2026
Trial IDNCT06931938 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include ICU patients diagnosed with acute hypoxemic respiratory failure due to pneumonia.

Probably not a fit

Patients under 18 years old, pregnant women, or those unlikely to comply with the study protocol may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of awake prone positioning on patients suffering from acute hypoxic respiratory failure (AHRF) due to pneumonia. It aims to determine whether this positioning is more effective than standard supine or semi-recumbent positions in reducing the need for tracheal intubation and all-cause mortality within 28 days. The study will also assess the safety and tolerability of this intervention in an intensive care unit setting. Patients will be monitored closely to evaluate outcomes related to their respiratory function and overall health.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the need for intubation and improve survival rates in patients with AHRF due to pneumonia.

How similar studies have gone: Previous studies have shown positive outcomes with awake prone positioning in intubated patients and those with COVID-19 pneumonia, but conclusive evidence for AHRF patients without COVID-19 is still lacking.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The focus of this trial is to treat patients with respiratory failure. The inclusion criteria are selected accordingly. Patients meeting all of the criteria listed below will be included in the study:

  * Patients in the intensive care unit
  * High possibility of Pneumonia (community-acquired pneumonia or hospital-acquired pneumo-nia) either diagnosed by chest x-ray or computed tomography or clinically diagnosed at least with one of the following signs

    * Appearance of purulent secretions or changes in characteristics (color, odor, quantity, consistency)
    * Cough or dyspnea or tachypnea
    * Evocative auscultation
  * Presence of acute hypoxemic respiratory failure (PaO2/FIO2 ≤ 300 mmHg or SpO2/FiO2 ≤ 315)

Exclusion Criteria:

* Patients are excluded from the study if any of the following criteria are met at screening or before ran-domization, a detailed list is shown in the study manual:

  * Age below 18
  * Pregnant woman
  * Patient is unlikely/unable to awake prone positioning, or to be compliant as indicated by the treating team
  * Prolonged need (≥ 4 days) for HFNO, NIV or CPAP before study inclusion
  * Urgent need for endotracheal intubation
  * Invasive Mechanical Ventilation
  * Shock

    o Defined as need for vasopressor ≥ 0.4 mcg/kg/min to maintain a mean blood pressure of ≥ 65 mmHg or systolic blood pressure ≥ 90 mmHg
  * Participation in another clinical interventional trial in the last 3 months
  * Previous Participation in the PROSA Trial
  * Long-term oxygenation therapy (LTOT) or continuous positive airway pressure (CPAP) therapy before hospital admission
  * Treatment

Where it's running

  • University Medical Center Hamburg-Eppendorf
    Hamburg, Free and Hanseatic City of Hamburg, Germany
    Recruiting

Study contacts

  • Principal investigator: Stefan Kluge, MD — Universitätsklinikum Hamburg-Eppendorf
  • Study coordinator: Kevin Roedl, MD
  • Email: k.roedl@uke.de
  • Phone: +49 40 7410 35315

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.